Leveraging Hypomethylating Agents for Better MDS Therapy

Overview of attention for article published in Current Hematologic Malignancy Reports, September 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 8 Mendeley

Summary X Patents

So far, Altmetric has seen 1 patent that references this research output.

AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS…

Application WO-2020257671-A1

World Intellectual Property Organisation (WIPO)